BSEM Exercise Disclosure
Smith-van Vurst Andrew · SEC Form 4 · Filed Sep 17, 2026
Exercise
Calculated transaction value
$0
Smith-van Vurst Andrew Chief Operating Officer
BSEM
Transaction date
Sep 17, 2026
Public filing date
Sep 17, 2026
Filing lag
Filed same day
BSEM daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Common Stock
- Quantity / price
- 9,574 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-394391
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Biostem Technologies, Inc. BSEM | Exercise | Sep 17, 2026 | $0 |
| Biostem Technologies, Inc. BSEM Current | Exercise | Sep 17, 2026 | $0 |
| Biostem Technologies, Inc. BSEM | Exercise | Sep 15, 2026 | $0 |
| Biostem Technologies, Inc. BSEM | Exercise | Sep 15, 2026 | $0 |